Total Payments
$7,310
2024 Payments
$866.81
Companies
28
Transactions
384
Medicare Patients
1,855
Medicare Billing
$151,392
Payment Breakdown by Category
Food & Beverage$6,742 (92.2%)
Other$400.00 (5.5%)
Education$168.35 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,742 | 379 | 92.2% |
| Honoraria | $400.00 | 1 | 5.5% |
| Education | $168.35 | 4 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,008 | 96 | $0 (2024) |
| Amgen Inc. | $1,126 | 85 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $701.88 | 23 | $0 (2024) |
| Celgene Corporation | $519.32 | 50 | $0 (2019) |
| Encore Dermatology Inc. | $400.00 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $397.51 | 22 | $0 (2024) |
| Lilly USA, LLC | $384.87 | 24 | $0 (2024) |
| PFIZER INC. | $365.38 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $364.22 | 17 | $0 (2024) |
| GENZYME CORPORATION | $202.90 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $866.81 | 42 | Amgen Inc. ($208.29) |
| 2023 | $1,096 | 61 | Amgen Inc. ($270.55) |
| 2022 | $888.13 | 47 | ABBVIE INC. ($241.43) |
| 2021 | $1,078 | 61 | AbbVie Inc. ($320.08) |
| 2020 | $842.82 | 42 | AbbVie Inc. ($268.15) |
| 2019 | $864.69 | 42 | AbbVie, Inc. ($485.04) |
| 2018 | $1,088 | 53 | Encore Dermatology Inc. ($400.00) |
| 2017 | $585.38 | 36 | Celgene Corporation ($275.94) |
All Payment Transactions
384 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Inflammation & Immunology | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.60 | General |
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $34.50 | General |
| 08/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Inflammation | ||||||
| 08/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Inflammation | ||||||
| 07/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Dermatology | ||||||
| 07/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: Inflammation | ||||||
| 07/08/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.46 | General |
| 07/01/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: DERMATOLOGY | ||||||
| 06/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Immunology | ||||||
| 06/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Inflammation | ||||||
| 06/03/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 407 | 552 | $62,300 | $36,366 |
| 2022 | 6 | 360 | 496 | $54,490 | $30,470 |
| 2021 | 6 | 429 | 610 | $67,896 | $40,196 |
| 2020 | 12 | 659 | 858 | $125,946 | $44,360 |
Total Patients
1,855
Total Services
2,516
Medicare Billing
$151,392
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 216 | 347 | $34,561 | $21,400 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 59 | $9,794 | $5,211 | 53.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 47 | 49 | $6,048 | $3,856 | 63.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $5,216 | $2,390 | 45.8% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 19 | 23 | $2,835 | $1,488 | 52.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 23 | 23 | $2,670 | $1,132 | 42.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 21 | $1,176 | $890.00 | 75.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 311 | $29,796 | $18,051 | 60.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 52 | $8,632 | $4,585 | 53.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 38 | 47 | $5,855 | $3,291 | 56.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 52 | 52 | $6,090 | $2,606 | 42.8% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2022 | 15 | 20 | $2,460 | $1,197 | 48.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 13 | 14 | $1,657 | $740.47 | 44.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 226 | 346 | $33,144 | $21,472 | 64.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 47 | $7,831 | $4,621 | 59.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 44 | 59 | $7,675 | $4,580 | 59.7% |
| 17260 | Destruction of malignant growth (0.5 centimeters or less) of trunk, arms, or legs | Office | 2021 | 22 | 37 | $4,595 | $2,892 | 62.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 50 | 50 | $5,805 | $2,796 | 48.2% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 13 | 39 | $4,520 | $1,657 | 36.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 15 | $2,490 | $1,189 | 47.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 17 | $1,836 | $988.89 | 53.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 245 | 321 | $39,890 | $16,060 | 40.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 95 | 108 | $20,693 | $7,633 | 36.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 55 | $13,736 | $4,609 | 33.6% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 78 | 78 | $12,614 | $4,181 | 33.1% |
About Dr. Gary Barsky, MD
Dr. Gary Barsky, MD is a Dermatology healthcare provider based in Elmhurst, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881756633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Barsky, MD has received a total of $7,310 in payments from pharmaceutical and medical device companies, with $866.81 received in 2024. These payments were reported across 384 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,742).
As a Medicare-enrolled provider, Barsky has provided services to 1,855 Medicare beneficiaries, totaling 2,516 services with total Medicare billing of $151,392. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Procedural Dermatology
- Location Elmhurst, IL
- Active Since 12/15/2006
- Last Updated 09/24/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881756633
Products in Payments
- Otezla (Drug) $922.40
- DUPIXENT (Biological) $873.00
- Humira (Biological) $820.96
- SKYRIZI (Biological) $711.21
- Enbrel (Biological) $435.54
- Impoyz (Drug) $400.00
- EUCRISA (Drug) $346.88
- TALTZ (Drug) $316.89
- HUMIRA (Biological) $291.36
- COSENTYX (Biological) $257.51
- TREMFYA (Drug) $221.68
- COSENTYX (Drug) $140.00
- ZILXI (Drug) $124.15
- ILUMYA (Biological) $100.91
- RINVOQ (Biological) $98.42
- Cimzia (Drug) $97.58
- REMICADE (Biological) $72.15
- Skyrizi (Biological) $67.39
- Tremfya (Drug) $55.46
- LIBTAYO (Biological) $51.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Elmhurst
Huachen Wei, Md, MD
Dermatology — Payments: $311,988
Dermatology $311,988
Dr. Julia Wu, Md, MD
Dermatology — Payments: $37,132
Dermatology $37,132
Marie Leger, Md, MD
Dermatology — Payments: $36,243
Dermatology $36,243
Todd Davis, Md, MD
Dermatology — Payments: $11,719
Dermatology $11,719
Dr. Nikki Kim, Md, MD
Dermatology — Payments: $6,104
Dermatology $6,104
Dr. Daniel Michalik, Md, MD
Dermatology — Payments: $4,628
Dermatology $4,628